regeneron vice president salary

He is a member of the National Academy of Sciences, the National Academy of Medicine, the Royal Society of London and the Royal Society of Canada. The information shown here is a reporting of information included in the company's proxy statement. Dr. Zoghbi has been a director of the company since 2016. Before that, she has led global marketing research, corporate strategy and DE&I efforts at Fortune 50 companies such as Prudential Financial, Johnson & Johnson and ACNielsen. from Cornell University and a J.D. David Weinreich, M.D., joined Regeneron in 2016 and serves as executive vice president, global clinical development. in pharmacy from Long Island University and an MBA from the University of Phoenix. GSK Mr. Ryan managed Chases worldwide retail bank between 1984 and 1990. at Saint Johns University. Prior to that she was chief diversity officer for Dow Jones, including its flagship brand, The Wall Street Journal. and B.S. Richard (Rich) ONeal joined Regeneron in 2018 and is the senior vice president of market access. Leonard (Len) Brooks joined Regeneron in 2013 and serves as senior vice president, treasurer. Gerald Underwood joined Regeneron in 1995 and serves as senior vice president, technical operations for the global industrial operations & product supply organization. The estimated additional pay is $212,201 per year. This report is not for commercial use. The estimated hourly pay at Regeneron ranges from approximately $13.69 per hour for Software Engineer to $71.96 per hour for IT Manager.. Browse 100 estimated salaries at Regeneron in the United States Dr. Soltys received his B.S. Prior to his current role, he served as Regenerons vice president of financial planning, and prior to joining Regeneron, he was vice president of finance at Mojave Therapeutics, Inc. The charts on this page feature a breakdown of the total annual pay for the top executives at REGENERON PHARMACEUTICALS, INC. as reported in their proxy statements. Gilead The average Regeneron hourly pay ranges from approximately $24 per hour for an Intern - Hourly to $148 per hour for a Director. Ms. McCourt began her career and spent 12 years at AstraZeneca, ultimately becoming chief operating officer for AstraZeneca U.S. She received her B.S. Dr. Stahl started his career at Regeneron as a staff scientist in discovery research working on cytokine receptor signaling, and he spearheaded the invention and development of Regenerons Trap Technology. and Ph.D. from the University of Wales in the UK. Sally A. Paull joined Regeneron in 2016 and now serves as executive vice president, human resources. She is a former executive-in-residence in the Department of Management and Human Resources and former dean and John W. Berry, Sr. Retired Chairman of the Board and Chief Executive Officer, Prudential Financial, Inc. Mr. Ryan has been a director of the company since 2003. Thank you to our incredible colleagues for making this truly a great place to work and a place where passion meets opportunity. from Binghamton University. She earned a B.S. Before joining the pharmaceutical industry, Dr. Hughes worked as a medical practitioner in the UK and U.S. Dr. Hughes earned a medical degree (MBBS) from The Royal Free Hospital and School of Medicine, London University, and an M.Sc. The total cash compensation, which includes bonus, and annual incentives, can vary anywhere from $429,290 to $619,990 with the average total cash compensation of $508,790. Each salary is associated with a real job position. Prior to joining Regeneron, Dr. Zambrowicz held roles of increasing responsibility from 1996 to 2015 at Lexicon Pharmaceuticals, Inc., ultimately serving as executive vice president and chief scientific officer. Gary Herman, M.D., joined Regeneron in 2015 and leads the early clinical development and experimental sciences (ECDES) function. She has been the chair of the Department of Molecular Biology and the Squibb Professor in Molecular Biology at Princeton University since 2003 and is a Howard Hughes Medical Institute investigator. He has also served as chair and chief executive officer of TRATE Enterprises LLC, a privately held company, since 2013. He has held leadership roles in quality, validation, regulatory, internal manufacturing and engineering. Salary Range (annually) $75,700.00 - $123,500.00 R17524 Seniority level Mid-Senior level Employment type Full-time Job function Research, Analyst, and Information Technology Industries. At Regeneron, we believe in the power of original thinking. He earned his B.S. Senior Vice President, Early Clinical Development and Experimental Sciences. Research & Science Based on 1040 salaries Research Associate 187 salaries Scientist 119 salaries View More Engineering Based on 355 salaries QC Analyst 28 salaries Engineering Co-Op 12 salaries View More She has received many scientific honors, including a MacArthur Foundation Fellowship, the Lounsbery Award, the Shaw Prize for Life Science and Medicine, the Gruber Prize in Genetics and the Wolf Prize in Chemistry. Senior Vice President, Preclinical Manufacturing and Process Development. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail Prior to joining Regeneron, Dr. Morton completed post-doctoral fellowships at Pfizer and Sloan Kettering Cancer Center. Prior to working at Regeneron, Mr. We encourage you to read the privacy policy of every website you visit. las molestias. , Find high paying available jobs at Regeneron Pharmaceuticals, Inc.For expert network information on Regeneron Pharmaceuticals, Inc compensation and careers, use Ladders $100K + Club. Als u dit bericht blijft zien, stuur dan een e-mail Thank you to our incredible colleagues for making this truly a great place to work and a place where passion meets opportunity. Aris Baras, M.D., joined Regeneron in 2011 and helped found the Regeneron Genetics Center (RGC), where he now serves as senior vice president. Scribe Therapeutics - Alameda Regeneron salary trends based on salaries posted anonymously by Regeneron employees. from the University of Wisconsin-Madison and his Ph.D. from the University of Washington. questo messaggio, invia un'email all'indirizzo Thomas DiCioccio, Ph.D., joined Regeneron in 2010 and serves as senior vice president, pharmacometrics. Before joining Regeneron, Dr. Sirulnik was chief medical officer at Merus N.V., a clinical-stage immuno-oncology company. Bob McCowan is senior vice president and chief information officer at Regeneron. Senior Vice President, Commercial Scale Manufacturing and Manufacturing Technology. Prior to joining Regeneron, Ms. Tegan worked at Ciba Specialty Chemicals and then as senior director/head of procurement at Purdue Pharma L.P., where she held roles of increasing responsibility. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. Onze Frederick Austin joined Regeneron in 2012 and serves as senior vice president, quality control, Raheen. from Virginia Polytechnic Institute and State University. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de Previously, he worked at Pfizer for 10 years focusing on research and early development of biologics, and before that he worked at Rinat Neuroscience Corporation after completing his postdoctoral fellowship at Genentech. message, contactez-nous l'adresse Aiutaci a proteggere Glassdoor dimostrando che sei una persona reale. This information is according to proxy statements . Senior Vice President, Global Development Scientific Council. Dr. Kyratsous previously worked at the Howard Hughes Medical Institute and was a postdoctoral fellow at New York University. per informarci del problema. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Average salary for AstraZeneca Vice President Finance in Burton Latimer, England: [salary]. George D. Yancopoulos, MD, PhD Co-Founder, President and Chief Scientific Officer View bio Corporate Leaders Zoran Berkovic Senior Vice President, Financial Planning and Analysis View bio Maya Bermingham Senior Vice President, Public Policy and Government Affairs View bio Christina Chan Daniel Van Plew joined Regeneron in 2007 and has served as executive vice president and general manager, industrial operations and product supply since January 2016. Senior Vice President and Site Head, IOPS Raheen. in Nigeria before moving to the U.S. for his residency at the University of Connecticut. Mr. LaRosa received his J.D. The total cash compensation, which includes bonus, and annual incentives, can vary anywhere from $271,190 to $333,590 with the average total cash compensation of $295,590. Takeda real person. Regeneron from the University of Rochester and a Ph.D. from State University of New York. Prior to joining Regeneron, Ms. Childrose worked at Albany Molecular Research Inc., and spent almost two decades at General Electric (GE) in positions of increasing responsibility. In addition, his team oversees regulatory functions including labeling and advertising/promotion and compliance. Randy Soltys, Ph.D., joined Regeneron in 2011 and now serves as senior vice president, drug safety and pharmacometrics, where he is responsible for the toxicology, pathology, preclinical PK/PD and clinicaland quantitative pharmacology organizations. Ms. Lozner earned a B.S. Copyright 2023 Regeneron Pharmaceuticals Inc. All rights reserved. Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. Dr. Schleifer is a licensed physician and is certified in neurology by the American Board of Psychiatry and Neurology. Bonus. Senior Vice President, Global Medical Affairs. Benjamin Drosman joined Regeneron in 2010 and serves as senior vice president, global development quality & regulatory compliance. Ms. Tegan received her B.S. , BMS Prior to joining Regeneron, Mr. Austin worked for 14 years at Amgen in various roles of increasing responsibility, including assisting in starting operations at the companys Longmont, Colorado, and Juncos, Puerto Rico sites, and spent time working at both Novartis and Abbott Laboratories. Prior to joining Regeneron, Ms. Bermingham held roles of increasing responsibility at PhRMA over a 12 year tenure, following earlier positions at legal firms, and work for Senator Moynihan and the Senate Finance Committee. in biology from Brown University, M.D. He received his A.B. Based in Tarrytown, New York, with an increasing global footprint, we focus on medicines that meet unmet. #bestplacetowork #careers, The average Regeneron salary ranges from approximately $52,103 per year for, Regeneron employees attributed a compensation and benefits rating of 4.2/5 stars to their company. Senior Vice President, Human Resources and HR Operations. Wir entschuldigen uns fr die Umstnde. Se continui a visualizzare Average salaries for Regeneron Vice President: [salary]. in Science from the University of California, Davis. in medicine and his M.D. How much do Regeneron employees make? Patrice Gilooly joined Regeneron in 1998 and serves as senior vice president, quality assurance and operations. The estimated total pay for a Vice President Operations at Regeneron is $448,608 per year. Ci The estimated additional pay is $171,268 per year. The estimated additional pay is $210,764 per year. Senior Vice President, Chief Compliance Officer. , He received his B.A. in molecular biology at the University of Wisconsin, and his Ph.D. in human genetics from Columbia University, College of Physicians and Surgeons. Maya Bermingham, J.D., joined Regeneron in 2015 and serves as senior vice president, public policy and government affairs. Regeneron Perspectives Advancing our commitment to diversity, equity & inclusion Fostering inclusion in our workplace and communities is a natural extension of our mission to improve lives Maya Bermingham, Interim Head of DE&I; Vice President, Government Affairs and Public Policy October 2, 2020 , He has held leadership positions of increasing responsibility in quality, regulatory affairs, program management and manufacturing across biological, small molecule and medical device platforms. Previously, he served in roles of increasing responsibility at Merck, most recently as the vice president and head, early stage development. Mastercard - Arlington